---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273731421.md"
description: "In Monday's trading session, health care stocks saw significant movements. Notable gainers included NewGenIvf Group (NIVF), which surged 187.5% to $1.45, and Check-Cap (MBAI), up 140.26% to $3.58. Other gainers included Acumen Pharmaceuticals (ABOS) at $2.37 (+19.88%) and Jin Medical International (ZJYL) at $0.16 (+17.68%). Conversely, NovaBay Pharmaceuticals (NBY) fell 32.2% to $3.19, while INVO Fertility (IVF) dropped 17.8% to $1.34. Revolution Medicines (RVMD) also saw a decline of 16.88% to $97.78."
datetime: "2026-01-26T17:05:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273731421.md)
  - [en](https://longbridge.com/en/news/273731421.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273731421.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **NewGenIvf Group** (NASDAQ:NIVF) shares increased by 187.5% to $1.45 during Monday's regular session.
-   **Check-Cap** (NASDAQ:MBAI) stock rose 140.26% to $3.58. The company's market cap stands at $9.1 million.
-   **Acumen Pharmaceuticals** (NASDAQ:ABOS) stock rose 19.88% to $2.37. The company's market cap stands at $119.9 million.
-   **Jin Medical International** (NASDAQ:ZJYL) shares increased by 17.68% to $0.16. The company's market cap stands at $20.9 million.
-   **Dermata Therapeutics** (NASDAQ:DRMA) stock increased by 16.58% to $2.53. The company's market cap stands at $6.1 million.
-   **TransCode Therapeutics** (NASDAQ:RNAZ) shares moved upwards by 15.29% to $11.38. The company's market cap stands at $9.0 million.

### Losers

-   **NovaBay Pharmaceuticals** (AMEX:NBY) shares declined by 32.2% to $3.19 during Monday's regular session. The market value of their outstanding shares is at $594.2 million.
-   **INVO Fertility** (NASDAQ:IVF) stock fell 17.8% to $1.34. The company's market cap stands at $24.6 million.
-   **Exicure** (NASDAQ:XCUR) stock declined by 17.21% to $5.1. The market value of their outstanding shares is at $39.2 million.
-   **Revolution Medicines** (NASDAQ:RVMD) stock fell 16.88% to $97.78. The market value of their outstanding shares is at $22.7 billion.
-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) stock decreased by 15.61% to $2.11. The market value of their outstanding shares is at $4.0 million.
-   **Medicus Pharma** (NASDAQ:MDCX) stock fell 14.6% to $1.17. The company's market cap stands at $33.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)
- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [NBY.US](https://longbridge.com/en/quote/NBY.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IVF.US](https://longbridge.com/en/quote/IVF.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [NIVF.US](https://longbridge.com/en/quote/NIVF.US.md)
- [ABOS.US](https://longbridge.com/en/quote/ABOS.US.md)
- [MBAI.US](https://longbridge.com/en/quote/MBAI.US.md)
- [SDEV.US](https://longbridge.com/en/quote/SDEV.US.md)

## Related News & Research

- [Billionaire Stanley Druckenmiller Continues to Load Up on Revolution Medicines. Does He Know Something Wall Street Doesn't?](https://longbridge.com/en/news/296885075.md)
- [Top 3 Health Care Stocks That May Keep You Up At Night In Q3](https://longbridge.com/en/news/297190336.md)
- [Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough Survival Results](https://longbridge.com/en/news/297207596.md)
- [Revolution Medicines CEO Mark A. Goldsmith reports disposal of common shares worth $16.87 million](https://longbridge.com/en/news/297030865.md)
- [Top Executive Makes a Major Move With Revolution Medicines Shares](https://longbridge.com/en/news/296974592.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**